Ginwa Enterprise Group Inc
Ginwa Enterprise (Group) Inc. researches, develops, produces, markets, and sells traditional Chinese medicines, biological drugs, and chemical drugs primarily in China. The company offers a range of orthopaedics, immunity, children, and general medicines in various dosage forms, including tablets, capsules, granules, powders, mixtures, oral solutions, syrups, and external solutions. It is also in… Read more
Market Cap & Net Worth: Ginwa Enterprise Group Inc (600080)
Ginwa Enterprise Group Inc (SHG:600080) has a market capitalization of $437.51 Million (CN¥3.21 Billion) as of March 18, 2026. Listed on the SHG stock exchange, this China-based company holds position #13521 globally and #3482 in its home market, demonstrating a 4.88% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ginwa Enterprise Group Inc's stock price CN¥8.60 by its total outstanding shares 373270285 (373.27 Million).
Ginwa Enterprise Group Inc Market Cap History: 2015 to 2026
Ginwa Enterprise Group Inc's market capitalization history from 2015 to 2026. Data shows change from $707.09 Million to $437.51 Million (-1.16% CAGR).
Ginwa Enterprise Group Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ginwa Enterprise Group Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.68x
Ginwa Enterprise Group Inc's market cap is 0.68 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
5.33x
Ginwa Enterprise Group Inc's market cap is 5.33 times its annual earnings
10.35x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $707.09 Million | $730.14 Million | $25.38 Million | 0.97x | 27.86x |
| 2016 | $619.75 Million | $666.65 Million | $27.30 Million | 0.93x | 22.70x |
| 2017 | $404.23 Million | $757.18 Million | $53.46 Million | 0.53x | 7.56x |
| 2018 | $355.39 Million | $745.16 Million | $38.32 Million | 0.48x | 9.27x |
| 2019 | $301.15 Million | $754.54 Million | $25.90 Million | 0.40x | 11.63x |
| 2020 | $280.78 Million | $668.18 Million | $37.74 Million | 0.42x | 7.44x |
| 2021 | $433.95 Million | $534.04 Million | -$18.16 Million | 0.81x | N/A |
| 2022 | $397.32 Million | $579.37 Million | $33.46 Million | 0.69x | 11.87x |
| 2023 | $379.01 Million | $565.40 Million | -$42.89 Million | 0.67x | N/A |
| 2024 | $397.32 Million | $585.46 Million | $74.61 Million | 0.68x | 5.33x |
Competitor Companies of 600080 by Market Capitalization
Companies near Ginwa Enterprise Group Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Ginwa Enterprise Group Inc by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Ginwa Enterprise Group Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Ginwa Enterprise Group Inc's market cap moved from $707.09 Million to $ 437.51 Million, with a yearly change of -1.16%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥437.51 Million | +14.06% |
| 2025 | CN¥383.59 Million | -3.46% |
| 2024 | CN¥397.32 Million | +4.83% |
| 2023 | CN¥379.01 Million | -4.61% |
| 2022 | CN¥397.32 Million | -8.44% |
| 2021 | CN¥433.95 Million | +54.55% |
| 2020 | CN¥280.78 Million | -6.76% |
| 2019 | CN¥301.15 Million | -15.26% |
| 2018 | CN¥355.39 Million | -12.08% |
| 2017 | CN¥404.23 Million | -34.78% |
| 2016 | CN¥619.75 Million | -12.35% |
| 2015 | CN¥707.09 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Ginwa Enterprise Group Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $437.51 Million USD |
| MoneyControl | $437.51 Million USD |
| MarketWatch | $437.51 Million USD |
| marketcap.company | $437.51 Million USD |
| Reuters | $437.51 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.